Latest market price
46.91
-1.37-2.84%
OverviewShort InterestFilings
ANABQT80AnaptysBio, Inc.·NASDAQ
46.91-2.84%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 02, 20264Statement of changes in beneficial ownership
Sep 21, 202610-KT10-KT
Sep 21, 20268-KCurrent report
Sep 17, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 20268-KCurrent report
Aug 07, 20264Statement of changes in beneficial ownership
Aug 07, 20264Statement of changes in beneficial ownership
Jul 30, 20268-KCurrent report
Jun 29, 2026ARSAnnual report to shareholders
Jun 29, 2026DEFA14AAdditional proxy soliciting materials
Jun 29, 2026DEF 14ADefinitive proxy statement
Jun 22, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 21, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20263Initial statement of beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20263Initial statement of beneficial ownership
May 12, 20268-KCurrent report
#1 / 25 of 339
Page
▼
/ 14